Skip to main content
OpenTrials
Completed

NCT Number: NCT01414959

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Methods: microdialysis, blood sampling, bronchoalveolar lavage

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • endotracheal intubation; pneumonia or complicated abdominal infection or complicated urinary tract infection

Exclusion criteria

  • allergy to doripenem, hemodialysis

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Aug 11, 2011
Registry last updated
Aug 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.